Barchart.com
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Jump-Start Your Search For Promising Trade Ideas With Barchart Premier’s "Top Stock Pick". FREE 30 Day Trial
Menu
Stocks | Futures | Watchlist | News | More
 
or
Watchlist | Portfolio | Dashboard
Site News
Contact
Market:
Menu

Fortress Biotech Inc (FBIO)

Fortress Biotech Inc (FBIO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Notes
Alerts
Watch
Help
Go To:
Checkpoint Therapeutics Announces FDA Approval of UNLOXCYT™ (cosibelimab-ipdl) GlobeNewswire - Fri Dec 13, 5:15PM CST

FBIO : 1.7200 (-1.15%)
CKPT : 3.75 (+11.28%)
Fortress Biotech Announces FDA Approval of Emrosi for Rosacea Treatment and Details Upcoming PDUFA for Cosibelimab Quiver Quantitative, Inc. - Fri Nov 15, 1:36AM CST

Fortress Biotech announced FDA approval for Emrosi for rosacea and a PDUFA date for cosibelimab. Financial results show a net loss.Quiver AI SummaryFortress Biotech, Inc. announced that its product Emrosi,...

FBIO : 1.7200 (-1.15%)
Fortress Biotech: Q3 Earnings Snapshot AP - Thu Nov 14, 4:04PM CST

Fortress Biotech: Q3 Earnings Snapshot

FBIO : 1.7200 (-1.15%)
Fortress Biotech Reports Third Quarter 2024 Financial Results and Recent Corporate Highlights GlobeNewswire - Thu Nov 14, 3:10PM CST

FBIO : 1.7200 (-1.15%)
FBIOP : 6.61 (-2.15%)
Checkpoint Therapeutics Reports Third Quarter 2024 Financial Results and Recent Corporate Updates GlobeNewswire - Tue Nov 12, 3:30PM CST

FBIO : 1.7200 (-1.15%)
CKPT : 3.75 (+11.28%)
Journey Medical Corporation Reports Third Quarter 2024 Financial Results and Recent Corporate Highlights GlobeNewswire - Tue Nov 12, 3:01PM CST

FBIO : 1.7200 (-1.15%)
DERM : 4.68 (+0.65%)
Journey Medical Corporation Announces U.S. FDA Approval of Emrosi™ (Minocycline Hydrochloride Extended Release Capsules, 40 mg) for the Treatment of Rosacea GlobeNewswire - Mon Nov 4, 6:00AM CST

FBIO : 1.7200 (-1.15%)
DERM : 4.68 (+0.65%)
Journey Medical Corporation Announces DFD-29 Data Presented at 44th Fall Clinical Dermatology Conference GlobeNewswire - Fri Oct 25, 7:30AM CDT

FBIO : 1.7200 (-1.15%)
DERM : 4.68 (+0.65%)
Avenue Therapeutics to Participate in Maxim Group’s 2024 Healthcare Virtual Summit GlobeNewswire - Wed Oct 9, 7:30AM CDT

FBIO : 1.7200 (-1.15%)
ATXI : 1.7700 (-1.67%)
Journey Medical Corporation to Participate in the 3rd Annual ROTH Healthcare Opportunities Conference GlobeNewswire - Thu Oct 3, 7:30AM CDT

FBIO : 1.7200 (-1.15%)
DERM : 4.68 (+0.65%)

Barchart Exclusives

Scalp a 47% Payout by the End of This Week with Micron (MU) Call Spreads Barchart - Sat Dec 21, 9:15AM CST
Yes, there are serious questions about MU stock following the underlying company’s disappointing earnings but a steady march is all options traders need. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar

[[ data.userDate ]]
[[ data.eventTime | date: 'EEE, MMM dd, yyyy h:mm a' ]] [[ zone ]]
Reserve Your Spot